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Purpose: To develop and validate a patient-centered, evaluative outcome measure to assess
patient-signiﬁcant and identiﬁed impacts of the three pediatric hip conditions (the “Quality of
Life, Concerns and Impact Measure” (QoLC&I)), for use by patients and clinicians in
discussions over treatment options and the evaluation of treatment and post-operative
rehabilitation.
Patients and methods: The measure was developed through a qualitative study, via two
web-based forums (patient narratives, n=84) and one specialist orthopedic adult hip clinic
(conducting interviews, n=38). The draft (1) measure was piloted in an asynchronous web-
based discussion group forum; following revision, it was piloted with a group of clinicians
and patients to assess its patient and clinical utility, face and content validity. The ﬁnal,
reﬁned prototype measure (QoLC&I, draft 3) was subjected to psychometric evaluation.
Results: A total of 230 patients provided useable data for the psychometric analysis: 70%
(160) had a conﬁrmed diagnosis of Developmental Dysplasia of the Hip, 15% (35) Perthes,
11% (26) Slipped Upper Femoral Epiphyses; 4% (9) PHC not stated. The scale showed good
acceptability (few missing items, good spread, low ﬂoor/ceiling effects), relevance (76%
stating they would ﬁnd the measure useful in their discussions with clinicians), and good
internal consistency (Cronbach’s α=0.98; average ICC=0.98). Hypotheses on convergent
validity (with the General Health Questionnaire, to measure depression, and the
International Hip Outcome Tool Short Form, to measure quality of life) and divergent
validity (with the General Self-Efﬁcacy Scale, to measure coping) were conﬁrmed.
Conclusion: The 64-item QoL&CI measure is a practical and valid measure addressing
areas of clinical and patient signiﬁcance and has potential value to assist patients and
clinicians in discussions about treatment choices and treatment progress. Future research
will address further psychometric testing (test–retest validity and responsiveness to change),
in additional sites, and embedding the measure into clinical practice.
Keywords: Developmental Dysplasia of the Hip, Perthes disease, Slipped Upper Femoral
Epiphyses, psychology, osteoarthritis
Introduction
Pediatric hip conditions
The three main pediatric hip conditions (PHCs) Perthes, Developmental Dysplasia of
the Hip (DDH), and Slipped Upper Femoral Epiphyses (SUFE) are all recognized as
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causes of early degenerative hip osteoarthritis in adults.
Many PHC patients will end up with painful arthritis at
some stage in their adult life and, if not identiﬁed early on,
may require a hip replacement at a young age. In DDH, the
hip socket is too shallow, and the femoral head is not held
tightly in place, so the hip joint is loose. In severe cases, the
femur can come out of the socket (dislocate). This results in
a mechanical overload of the anterolateral acetabular rim and
labrum. The clinical diagnosis of DDH is conﬁrmed by
sonographic imaging (in the ﬁrst months of life), while late
presenting pathological DDH (>6 months of age) is usually
diagnosed by an X-ray(s) of the pelvis. Dysplasia, subluxa-
tion, and dislocation of the hip joint are often associated with
the development of premature osteoarthritis (OA) in young
adults.2 Perthes disease occurs when the blood supply to the
head of the femur (thighbone) is temporarily disrupted.
Without an adequate blood supply, the bone cells die,
a process called avascular necrosis and the head of the
femur then becomes mis-shaped. The condition is most
commonly found in children between the ages of 4 and 8,
but it has also been identiﬁed in children and adolescents
between the ages of 2 and 15.1 In the long term, the mis-
shapen femoral head can remain so that it produces
a permanent deformity, which increases the risk of develop-
ing osteoarthritis in adults1 Slipped Upper Femoral
Epiphysis is a condition that happens in late childhood/
early adolescence; in this condition, the epiphysis of the
femoral head displaces or slips out of alignment from the
rest of the femur. The longer-term implications of this hap-
pening are that there is a change in shape of the hip joint.
It is widely accepted that, for PHCs, an early diagnosis is
most beneﬁcial, but many cases go undetected until later
childhood, adolescence, or early adulthood. This can result
in a lifetime of signiﬁcant long-termmorbidity, including gait
abnormalities, chronic pain, and premature degenerative
arthritis of the hip and leads to a number of very invasive
surgeries.3 In essence, all three conditions can lead to pre-
mature arthritis of the hip in later years. The extent of OA
depends on how severely the shape of the hip joint is altered
by the disease. All the PHCs are complex conditions that are
often hard to diagnose, and later early adult manifestation can
lead to prolonged disability. Patients will frequently present
with symptoms in adolescence or young adulthood, although
sometimes they present at older ages, in their 40s or 50s.
Unless the PHC is diagnosed promptly, patients will experi-
ence pre-arthritic symptoms associated with anterolateral
labral tears and synovial cysts which eventually progress to
articular cartilage degeneration, unless the hip joint
mechanics are corrected by surgical intervention2 The dis-
ease progression from pre-surgery presentation, through to
corrective surgery to post-surgery and extensive periods of
rehabilitation can have serious health implications for the
young population affected by these conditions. Corrective
surgery for these conditions is very invasive followed by
a long period of rehabilitation.
The treatment of arthritic hip disease in young patients
is a rapidly evolving area. Surgical acetabular reorientation
is the most common surgical approach and can optimize
femoral head coverage, decrease articular cartilage load-
ing, delay or prevent the development of secondary
osteoarthritis, and enhance patient function and activity2
Treatment is most successful during the early arthritic
phase of the disease; thus, early diagnosis is important.
However, Nunley2 found that patients with DDH were
taking an average of 5.1 years to be diagnosed, by which
time symptoms become more profound. If arthritis has
progressed, then the options for treatment become more
limited. Most commonly, the only option is to replace the
hip, which for young patients can mean further revisions
throughout their life and can also cause signiﬁcant psy-
chological distress.3
Surgery is often very invasive, and patients can expect
to be walking with crutches for 8–12 weeks followed by
a prolonged period of rehabilitation. The rehabilitation
process is difﬁcult, and it can take up to one year for
a patient to fully feel the beneﬁts of surgery. Treatment
of borderline cases is also controversial. Hip arthroscopy
has often been the chosen treatment, but it carries a high
risk of reoperation. A broad range of surgeries now exists,
but no comparison studies have been conducted to look at
their effectiveness. There is great uncertainty about the
effectiveness of treatment, compounded by lack of agree-
ment about which outcomes should be measured. Very few
studies exist that focus on the patient experience of surgery
and recovery and rehabilitation.
We know very little about the quality of life (QoL)
and psychological impact of PHCs. If left undetected or
untreated, they may lead to signiﬁcant pain and func-
tional problems which will greatly impact on everyday
life (for example, ongoing pain, effect on exercise,
family and social life) and QoL.4,5 For some, this will
lead to profound disability associated with progressive
hip degeneration and eventual end-stage disease.
Additionally, little research has been conducted on the
impact of adult hip conditions focusing on early pre-
sentation and symptoms.
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The impact of the conditions throughout presentation,
diagnosis, treatment, and longer-term effects on patient
QoL can be quite signiﬁcant. For example, patients can
face a lifetime of uncertainty as to what the longer-term
effects of hip dysplasia are. Long-term studies of surgical
treatment for DDH have shown that periacetabular osteot-
omy (PAO) can last for up to 20 years if the patients had
no cartilage damage at the time of surgery. In these
studies,6–9 failure was deﬁned as revision to a total hip
replacement (THR) and many PAO’s do not last as long as
20 years. What is not clear from the literature is the long-
term impact on a patient’s physical and socio-
psychological well-being in their everyday life.
Measuring PHC outcomes
Careful selection of meaningful outcome measures is cru-
cial in conducting clinical trials to include outcomes that
matter to patients. A recent systematic review of the efﬁ-
cacy of PAO’s highlighted that there was a lot of variance
in the way that studies reported clinical outcomes.10 This
study highlighted that progress in this ﬁeld is dependent on
measuring accurate, clear, and consistent outcomes which
in turn is dependent on the development of new validated,
patient-based outcome measures. This would allow more
precise and wide-ranging analysis of clinical improve-
ment. In young adult hips, operative success has been
measured by using objective measures such as radiologic
imaging which measures the anatomical variation in the
hip and how it varies from normal and deformity correc-
tion after surgery, improvements in range of motion are
also measured.11 Additionally, standardized hip outcome
scores are frequently used in the literature including the
modiﬁed Harris Hip Score (mHHS), Hip Outcome score
Activities of Daily Living (HOS-ADL), HOS-Sport-
Speciﬁc Subscales (HOS-SSS), 12-item Short Form
Health Survey (SF-12), and Western Ontario and
McMaster Universities Osteoarthritis Index
(WOMAC).12–15 The scores have all been validated for
assessing advanced OA in a much older population, but
they may not be ﬁt for purpose in a young adult hip
population. Young adults often have higher physical activ-
ity expectations and outcomes will vary. For example,
being able to simply complete daily activities of life may
not be deemed a positive outcome in young adults.15–17
These measures do not always embrace high impact activ-
ities that young adults will demand of their hips post-
operatively.15–17
For patients undergoing hip preservation surgery,
patient-reported outcome (PRO) measures are becoming
an integral part of measuring the efﬁcacy of treatment.
Ramisetty et al18 conducted a systematic review, their
speciﬁc aim was to critically appraise the quality of
PRO’s in order to recommend the most appropriate PRO
tool(s) for future use. They included studies which com-
pared patients with a variety of hip conditions, and surgi-
cal methods used to treat the conditions, including
arthroscopy and surgery for dysplastic and non-dysplastic
hips. Six PRO tools from ten articles were identiﬁed. The
most recently developed PRO tools - the hip outcome
score (HOS), the Copenhagen hip and groin outcome
score (HAGOS) and the International Hip Outcome Tool
(iHOT-33) - scored better than the others. The iHOT-33
scored best of all the PRO tools, and they recommended it
for future use in hip preservation surgery. The iHOT-33
was developed with the cooperation of the multi-center
arthroscopy of the hip outcomes research network
(MAHORN) and it was designed to measure the outcomes
of treatment in young active patients with hip disorders
(18 or older and up to 60 years old). However, this mea-
sure has primarily been used in patients undergoing arthro-
scopy. Many would argue that these patients are not as
debilitated as patients with more severe hip dysplasia,
Perthes, and SUFE who are undergoing osteotomies. It is
also noticeable that psychological impact is not measured
in any of the measures reviewed in this study despite this
being a signiﬁcant factor for adult patients with a PHC.4
Broader outcome measures used in hip
studies
Sim et al (2015)19 conducted a systematic review to eval-
uate the reporting of non-hip score outcomes following
surgical management of femora-acetabular impingement
(FAI). Patients diagnosed with hip dysplasia and Perthes
can also have impingement. The most common non-hip
score outcomes reported included: patient satisfaction
(72.7%), symptom improvement (24.7%), pain improve-
ment (12.4%), hip range of motion (12.3%), and return to
sport (6.8%)19 What is interesting about this study is that
a discrepancy exists between what outcomes the literature
suggests should be reported and what outcomes are often
reported. For example, “return to sport” is often held as
a major patient-important outcome yet it is rarely reported
in studies assessing the efﬁcacy of FAI surgery. This
systematic review highlighted differences between what
Dovepress Gambling and Long
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patients consider to be an important outcome and non-hip
score outcomes reported in the literature.19 Impellizzeri
et al20 also found that “reduction in hip pain” was the
most cited reason for pursuing surgery, followed by ability
to “return to sport”. This lends further credence to the need
for outcome measures focused on young people which
measure aspects important to their needs and can be incor-
porated clinical trials. Although most research in hip dys-
plasia has focused on pain and function, there has been
a recent and growing interest in measuring the real-world
impact on patients through broader assessments of QoL.
Several studies have focused on the emerging area of
movement and movement analysis21 Movement analysis
provides an objective examination of hip mechanics in the
patient and therefore measures different aspects of the
effects of hip dysplasia. Problems with walking have
been documented in patients with untreated hip
dysplasia.21–24 This can have a signiﬁcant impact on
patients as they will walk with a deﬁned limp and abnor-
mal-appearing posture. However, its physical and psycho-
logical impact and impact on body image are to date
unexplored.
Hip pain itself may prevent participation in social,
recreational, and sports activities and directly impact
QoL. Numerous studies on outcomes after PAO focus
on instruments of QoL and hip function such as the
WOMAC and the Harris Hip Score.17 Although these
instruments provide information about patients’ func-
tional limitations and pain, they do not directly assess
activity level and sports participation. Patients who par-
ticipated in sports before surgery may wish to resume
their activities after surgery. The “wish to return to
recreation” often is cited by patients with hip pain as
an important component of their disability.25 There is
limited evidence, to date, regarding the physical activity
levels patients can expect to achieve after surgery and
which factors may affect resumption of or improvement
on preoperative activity levels. Simple scores from
a questionnaire may not give the full picture as patients
may change activities by reducing impact sports. For
example, Klit et al26 studied activity in patients with
hip dysplasia seven years after PAO. The relatively low
visual analog scores together with the relatively low
score in the dimensions “sport and recreation” and “par-
ticipation” may indicate that the patients reduce their
sport activities and participation after PAO to minimize
their symptoms, but at a psychological price, involving
trying to manage expectations.
There is also limited research considering broader aspects
of QoL post-surgery. For example, “return to work” was
studied in only one study27 This paper also considered that
“limb length discrepancy”was an important factor for patient
morale, motivation, and post-operative satisfaction. Some
research28 has been conducted considering “insomnia and
sleep” and their overall impact on QoL. Gambling and Long
(2013),3 in their qualitative studies, also found that many
patients struggled with their body image and self-esteem if
there were long delays in diagnosis. Currently, measures do
not exist which consider this global impact of PHCs in young
adults. Furthermore, Perthes, with its occurrence in very
young children, is a challenging area for instrument devel-
opment; however, work is being conducted to develop an
outcome measure for children with Perthes.29
In summary, little is known about the psychological,
economic, and personal impact of pediatric hip
conditions.30 This lack of evidence makes it very difﬁcult
to assess patient need and evaluate treatments that best
support patients. Whilst it is known that surgery can pro-
vide pain relief and improve hip function, the availability
and use of an appropriate outcome measure focused on
patient concerns and the potential impact of hip dysplasia
on a broad range of factors, including pain, psychological
health, social and familial impact, and QoL, would poten-
tially improve treatment experience and patient–clinician
interactions and provide an additional tool to use within
the evaluation of clinical practice.
This paper reports on the development of an outcome
measure to assess the patient-signiﬁcant and patient-
identiﬁed impact of PHCs. The aim was to develop a patient-
centered,31 evaluative32 outcome measure for pediatric hip
conditions (the “Quality of Life, Concerns and Impact
Measure” - QoLC&I) to be used by both patients and clin-
icians in discussions over treatment options and the evaluation
of treatment and post-operative rehabilitation. Our guiding
criteria were multiple, for the measure: to be based on the
patient’s perspective and thus be user-centered; to have clinical
utility and feasibility to use in clinical practice; and to have
good psychometric properties (reliability, validity, and respon-
siveness to change). Appendix 1 summarizes the detail of our
requirements.33,34,35 For a measure to be used in practice, it
must also be of perceived high relevance to patients’ concerns
and useful for them and clinicians.31 Our measure has been
designed to do this and is based on previous qualitative
research. The implementation of the outcome measure would
enable a clearer picture of the QoL impact and wider social
and psychological impact on pediatric hip conditions.
Gambling and Long Dovepress
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The measure is intended to add insight into physical,
social, psychological, self-esteem and QoL factors of impor-
tance to patients and widen understanding about both patient
treatment responses and factors that patients’ value. As out-
lined above, limited knowledge of the socio-psychological and
QoL effects of these conditions results in a clinical emphasis
on physical/functional problems, without consideration of the
wider social and psychological impact. The implementation of
the outcome measure would enable a clearer picture of the
QoL impact and wider social and psychological impact on
PHCs. An overview of the study design for the development
and validation of the measure is presented in Figure 1.
Methods
Development phase
A qualitative study was conducted (2013-early 2015),
drawing on two sources: two web-based forums (using
patient narratives) and a specialist orthopedic adult hip
clinic (conducting interviews).
Participants were carefully selected, using the princi-
ple of diversity from the web sources. The use of two
websites enabled diversity, allowing access to partici-
pants from a wider geographical area, some being close
to specialist centers and others much further away; this
would inﬂuence the nature and possibly quality of the
care they had or were receiving. In addition, we were
potentially able to recruit patients internationally, from
the USA, Australia, and Europe. Recruiting from one
specialist adult hip clinic (in the Royal Orthopaedic
Hospital NHS Foundation Trust, Birmingham) enabled
insight into the perspective of patients who were receiv-
ing the best care.
The aim was to recruit around 100 participants from
the two sources and to ensure variability in time of ﬁrst
diagnosis (childhood or adulthood), clinical presentational
time (pre or up to 12 months post-operative), and treat-
ment stage (preventive, “to save my joints” or treatment
following points of failure). By carefully selecting partici-
pants to ensure the potential for the expression of different
experiences, such a sample size was expected to capture
the required depth and richness of data. Ethical approval
was given by Cardiff University Ethics Committee for the
websites and NHS Ethical Committee (the Royal
Orthopaedic Hospital NHS Foundation Trust) for the spe-
cialist clinic; the latter committee deemed the study as
evaluation and thus as part of clinical practice
development.
Inclusion criteria were
● Women and men with a conﬁrmed diagnosis of
DDH, Perthes, or SUFE
● Having an extensive DDH-, Perthes-, or SUFE-
related treatment history following diagnosis in
childhood/adolescence or newly diagnosed as young
adults or following a recurrence/new symptom
● Aged 18 or over
● English speakers
● Active member of one of the two web forums/or
attending the specialist orthopedic hip clinic.
Patient recruitment
To recruit participants from the web sources, the site mod-
erators were asked if they would allow access to their sites.
Once agreement was ascertained, a message was posted on
the websites seeking volunteers who ﬁtted the research
eligibility criteria. The message directed interested persons
to a secure University of Cardiff-hosted website where
further information about the research project was posted.
Participants completed an electronic consent form, which
included their e-mail contact details. Participants were then
asked to complete a simple screening questionnaire. If they
ﬁtted the study criteria, they were invited to write
a narrative about their experiences, covering, for example,
their diagnosis, treatment history, treatment experiences and
impact of the PHC on their lives and sense of self and
feelings about the future. To assist their story writing, an
indicative structure36,37 was provided of key areas to frame
their story around, while encouraging them to write up their
personal history in any way that they wished.
In the specialist hip clinics, patients were recruited via the
consultant hip surgeon who applied the inclusion criteria,
dividing planned clinic consultations by type of visit (discuss
treatment options, follow-up 6 weeks to 24 months post-
treatment). The appointment clerk in each site sent consecu-
tive patients meeting the inclusion criteria a participant infor-
mation sheet, consent pro forma and, for the later part of the
study, the draft outcomemeasure. Patients willing to take part
in the study were asked to bring the completed consent pro
forma and, where relevant, the completed outcome measure
to their next clinic appointment. Data were collected on 84
patients through the websites and 38 patients from the clinics.
Data analysis
Data were analyzed in a thematic manner, exploring partici-
pants’ meanings surrounding particular experiences, events,
and states. A set of emerging themes (Figure 2) provided the
Dovepress Gambling and Long
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basis for an initial model speciﬁcation. These areas high-
lighted the impact of the condition and their concerns. They
covered pain, physical activity, work, family and social
impact, psychological impact, and overall QoL.
The topic areas, or domains, were translated into ques-
tions, built around a ﬁve-level Likert scale, and a draft
measure developed and then piloted. Firstly, the draft (1)
measure was piloted with a subset of the online recruited
participants (n=30), using an asynchronous38 web-based dis-
cussion group design, asking them to comment on the ease of
understanding of its content, accessibility of language, ease
of completion and coverage, including missing or suggested
Recruitment from
PHASE ONE: qualitative study: uncovering perspectives of persons with a PHC:
target sample size 100 persons with a PHC
methods: patient stories/nar ratives, patient interviews
PHASE TWO: piloting of measure, draft 1: item content, face and content validity
target sample size: 30 persons with  PHC
methods: web- based discussion forum over two-week period
PHASE THREE: piloting of measure, draft 2: clinical and patient utility
target sample size: 15 persons, 15 practitioners
methods: retrospective probing in congnitive interviews, observation
PHASE FOUR: psychometric validation, prototype QOLC&l measure
target sample size: n=250
methods: cross-sectional survey based on a retrospective pre-test design
Two web forum:
n=84, patient
n=30: asynchronous
web-based
discussion group
Specialist adult hip clinic:
15 patients and 2 hip
consultants interviews; 10
consultation observations
Specialist adult hip clinic:
n=230 completed
questionnaires for the 3
PHCs (DDH, perthes,SUFE)
stories
Recruitment from
specialist adult hip
clinic:
n=38, patient interviews
Figure 1 Overview of development and validation study design.
Abbreviations: QOL, quality of life; QOLC&I, quality of life concerns and impact; DDH, developmental dysplasia of the hip; SUFE, slipped upper femoral Epiphyses.
Gambling and Long Dovepress
submit your manuscript | www.dovepress.com
DovePress
Patient Related Outcome Measures 2019:10192
 
Pa
tie
nt
 R
el
at
ed
 O
ut
co
m
e 
M
ea
su
re
s 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
1.
25
1.
25
4.
63
 o
n 
19
-J
ul
-2
01
9
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
additional areas and question phrasing. The asynchronous
nature meant that participants did not have to be present at
the same time. Participants contributed their comments by
responding to the initial discussion question or by responding
to each other. All these responses were shown in the form of
an outline or thread so that responses appeared following the
entry to which they were replying. This discussion took place
over a deﬁned two-week period and wasmoderated by one of
the research team (TG). Working together with the partici-
pants, enabling co-construction of the measure, ensured the
patient-centered focus of the measure. The results of the pilot
were analyzed with a view to reﬁne the form, mode, and
coverage of the questions within the measure in order to
develop a revised outcome measure (draft 2) for psycho-
metric validation.
Second, this reﬁned measure (draft 2) was piloted with
both a group of clinicians and patients to assess its patient
and clinical utility. The rationale for this further piloting
related to the notion that, the more a measure focuses on
aspects that matter to patients and to clinicians, the greater
its validity, usefulness and likelihood of take-up by
patients and into clinical practice. A target sample size of
5 practitioners and 15 patient interviews was set. Given the
in-depth interview process, this sample size was sufﬁcient
to enable insight into the potential utility of the measure
and ways to enhance this.39
In-depth interviews supplemented with observation
were used. Patients attending for a consultation at the
Birmingham specialist hip clinic were asked to: complete
the prototype the “Quality of Life, Concerns and Impact
Measure” (draft 2) measure prior to their clinical consulta-
tion; share the completed measure with the practitioner;
and take part in a semi-structured post-consultation inter-
view. To assess face and content validity, a sample of 20
patients took part. Each patient participant was inter-
viewed using a semi-structured instrument, at the end of
their consultation (if convenient to the patient) or take part
in a telephone interview at an agreed date and time. The
interview used retrospective verbal probing, an established
approach within cognitive interviews,40,41 and recom-
mended way to clarify the participant’s understanding of
the items and use of a new instrument (DeWalt et al
2007).42 The interview explored: how their responses to
the measure were used in the consultation; how useful/
helpful they found this; how useful and relevant they
found the items in the measure; perceived potential value
of the measure in assessing/recognizing changes in their
condition; and ways that the measure’s utility might be
increased.
The practitioners were asked to: talk through the
patient’s responses to the items in the measure, as relevant
to the consultation’s focus; at consultation/clinic end, write
QoL: “The problems with my
hip have affected my whole
life. I am constantly tired and
in pain and now do very little
in terms of going out”
Education: “I had to
delay university; I
started but struggled
to cope. Just getting
to uni and moving
around were too hard.
i also felt very low and
isolated”
Physical activity: “I am so
upset i can no lonfer go to
the gym or run.....i am
trying to keep in shape by
swimming and cycling on a
stationary bike but it’s
hard”
Physical: “My hips have
affected my relationship
physically i am in constant pain
and my mobility is limited; I’m
always exhausted sex is the
last thing i can do; I think my
partner understands but i
worried he will get fed up.
Family: “I had to move back in
with my parents, which helped
daily things like washing,
shopping cooking. But it’s like
losing your independence”
Pain: “The pain is hard to manage
some days i feel ok, just a mild
dull ache; others it’s excruciating,
i have to plan and pace myself
and not do too much at once. It
starts to dominate your life.”
Depression: “l’ve felt very low
and depressed. it’s the
uncertainty of what will
happen. I’m not myself
anymore,” “I lack the
confidence to go out and meet
new people i avoid trips and
meetings in work”
Body image: “I am not able
to exercise so have
gained weight and lost
tone,i’m not happy with
the way i look. It’s really
affected my friendships
and social life”
Body image
& self-
esteem
Depression &
confidence
Physical
intimacy
Quality of
life impact
Physical
activity:
sports &
exercise
Work &
education
Pain
impact
Family&
social life
Figure 2 Emerging themes and illustrative extracts.
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down perceptions of the usefulness of the instrument in
assisting in the discussion with the patient over treatment
options for subsequent sharing with the research team; and
take part in an open-ended interview at the end of patient
data collection. One interview with each hip consultant
was conducted sharing their earlier notes on the usefulness
of the measure. The interview used “retrospective” verbal
probing, exploring how they made use of the measure in
the consultation in general and the potential value of the
measure in assessing changes in symptoms and impact;
and ways that the measure’s utility might be increased.
Four practitioners, the only ones with whom the patients
had a consultation, were interviewed.
To gain additional insight into how the consultants used
the measure, a member of the research team observed a small
number (10) of their consultations, with the patient’s permis-
sion. All interviews were audiotaped and transcribed, and
ﬁeld notes made for the clinic consultation observation.
Directed content analysis43 was used, drawing on the core
interview question headings, with an openness to additional
areas, to summarize perceived utility, ways to enhance this
and factors facilitating and inhibiting utility.
Following data analysis, a prototype (draft 3) measure
was created ready for psychometric evaluation, based around
the ﬁnal conceptual model (Figure 3). The measure was
targeted at persons with a PHC aged 16 years to 49 years.
Testing and validation phase
Study design
A cross-sectional survey based on a retrospective pre-test
design was used to explore measure validity. Test–retest
validity and responsiveness to change were left for latter
evaluation, due to administrative difﬁculties in the hip
clinic in following up and re-contacting respondents. The
retrospective pre-test design allowed respondents to report
on their contemporary and retrospective (3 months before),
in one section relating to QoL from the same individual
reference point (with the beneﬁt of knowledge of how
their condition had changed). This design is recognized
as being realistic, feasible, efﬁcient, and reducing the like-
lihood of missing data44 and of demonstrable value where
interest lies in changes in health-related quality of life.45
To assess validity, a target sample size of 250 was set
(125 for DDH; 125 for Perthes and SUFE together), cal-
culated on the basis of recommended guidance on mini-
mum number of cases (5) per item in the prototype
measure and a 95% conﬁdence interval for Cronbach’s
alpha (reliability) coefﬁcient of ≥0.746 and the measure
having a maximum of 25–30 items. To ensure this target
level was achieved, a 25% allowance for “not responding
to invitation to participate” (participation rate) and a 25%
allowance for subsequent “non-response to questionnaire
completion” was made, leading to a sample size of around
375–400. NHS Ethical approval was provided by the
Royal Orthopaedic Hospital NHS Foundation Trust
Birmingham, and the research was conducted in the spe-
cialist hip in that site, over the time period, 2015–2016.
Recruitment process
Following informed consent and a signed consent form,
the site’s research nurse gave each participant a copy of
the questionnaire measure and, if necessary, a stamped
addressed envelope to return the questionnaire to the
research team. Patients were requested to complete the
measure in relation to the hip they were currently receiv-
ing treatment for or, if both hips were symptomatic, the
most problematic hip. Non-responders at this stage were
sent, by the research nurse, one reminder letter only after
two weeks, together with another copy of the question-
naire. Any non-responders after this were considered as
refusals. The participants were asked to: complete the
“Quality of Life, Concerns and Impact Measure” measure,
together with short pro-forma seeking additional demo-
graphic (age, gender) and condition related data (height,
weight, hip condition, length of time from the onset of
symptoms to the deﬁnitive diagnosis).
Procedures and measures
The prototype measure had nine domains (Symptoms (11
items); Education and Work (3); Sports and Exercise (7);
Family Life (3); Physical Intimacy (3); Social Life and
Relationships with Others (5); Conﬁdence and Esteem (6);
Body Image (10); and Overall QoL (14)) and three open
questions relating to hopes and fears and potential useful-
ness of the measure in discussions with their clinicians
(see Appendix 2 for a copy of the measure). To assess
practicality, respondents were also asked to rate the ease of
completion and time taken to complete the measure.
To explore construct validity (convergent and diver-
gent), all participants were also asked to complete some
additional, validated tools which measured domains of the
prototype measure. Patients’ self-esteem, body image, and
feelings of self-efﬁcacy and quality of life were explored,
using the following measures:
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● Depression: General Health Questionnaire (GHQ)
(10 items)47
● Quality of Life: International Hip Outcome Tool
(iHOT-12) (12 items)16
● Coping: General Self-Efﬁcacy Scale (GSE).48
Psychometric analysis
Items were subjected to statistical examination, using IBM
SPSS for Windows versions 19–23 (SPSS Inc. Armonk,
NY, USA), to explore issue of acceptability and practicality
(response rate, missing item proportions, relevance to
treatment decision-making), item analysis (item redun-
dancy), reliability (internal consistency), and convergent/
discriminant validity (Appendix 1). Following redundancy
analysis, the psychometric properties of the reduced item
version were assessed.
Findings
Respondents
As Table 1 shows, the sample 230 persons comprised 160
(70%) persons with a conﬁrmed diagnosis of DDH, 35
Scale Factor Sub-factor (no. of items)
Pain symptoms and 
concerns (11)
1.Education & work (3)
2: Sport and exercise (6)
3: Family life (3)
4: Physical intimacy (3)
5. Social life (5)
Pain
concerns
Sport, work,
family & social
impact
Quality of life,
concerns and
impact
Psychological
impact
Quality of
life impact Overall quality of life(14)
3. Confidence and esteem (6)
2. Body image (7)
1.Emotion and depression (6)
Figure 3 Model speciﬁcation for the quality of life, concerns, and impact measure.
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Table 1 Respondent characteristicsa
Variable DDH Perthes SUFE
Diagnosed condition 72% (n=160) 16% (n=35) 12% (n=26)
Age (years) (n=155) (n=32) (n=26)
● Mean (standard deviation) 30.4 (8.4) 26.2 (6.8) 23.9 (6.5)
● Median (range) 30 (16–45) 25 (16–40) 22 (16–39)
● Aged under 20 n (%) 18 (12%) 6 (19%) 10 (39%)
● Aged 20-<35 n(%) 81(52%) 22 (58%) 14 (54%)
● Aged 35 or over n(%) 56 (36%) 4 (13%) 2 (8%)
Gender (n=155) (n=32) (n=26)
● Male 26 (17%) 24 (75%) 12 (46%)
● Female 129 (83%) 8 (25%) 14 (54%)
Age and gender by diagnosis (n=155) (n=32) (n=26)
Gender Age
<20
Age
20–<35
Age ≥35 Age
<20
Age
20–<35
Age
≥35
Age
<20
Age
20-<35
Age
≥35
● Male 1 13 12 4 17 3 5 6 1
● Female 17 68 44 2 5 1 5 8 0
Job status: (n=160) (n=32) (n=26)
● Employed (full or part-time) 102 (64%) 22 (69%) 10 (38%)
● Not working due to ill-health 21 (13%) 3 (10%) 3 (12%)
● In education (school or FE) 23 (14%) 5 (16%) 9 (35%)
● Looking after family 9 (6%) 1 (3%) 3 (12%)
● Unemployed 5 (3%) 1 (3%) 1 (4%)
Time to diagnosis (years) (n=144) (n=26) (n=20)
● Mean (SD) 2.6 (5.5) 0.33 (0.33) 1.5 (3.3)
● Median (range) 0.5 (0–33) 0.10 (0.1–1) 0.1 (0–13)
Stage of treatment:
left hip
(n=110) (n=23) (n=20)
● Deciding on treatment 52 (47%) 11 (48%) 8 (40%)
● Waiting for surgery 23 (21%) 2 (9%) 1 (5%)
● Up to 12 months post-op 20 (18%) 2 (9%) 4 (20%)
● Over 12 months post-op 15 (14%) 8 (35%) 7 (35%)
Stage of treatment:
right hip
(n=119) (n=18) (n=20)
● Deciding on treatment 49 (41%) 9 (50%) 10 (50%)
● Waiting for surgery 21 (18%) 3 (17%) 1 (5%)
● Up to 12 months post-op 25 (21%) 4 (22%) 4 (20%)
● Over 12 months post-op 24 (20%) 2 (11%) 5 (25%)
Type of surgery:
left hip
(n=107) (n=23) (n=18)
● Joint conservation 45 (42%) 3 (13%) 5 (28%)
● Triple/femoral osteotomy 9 (8%) 4 (17%) 2 (11%)
● Resurfacing surgery 6 (6%) 4 (17%) 1 (6%)
● Total hip replacement 12 (11%) 4 (17%) 2 (11%)
● Other 5 (5%) 3 (13%) 2 (11%)
● Don’t know 30 (28%) 5 (22%) 6 (33%)
(Continued)
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(15%) with Perthes and 26 (11%) with SUFE; nine (4%)
of the respondents did not indicate which PHC they had).
The age and gender variation by condition, were as
expected,1,49 similar to other studies. For example, 44%
of those with DDH were female and aged 20–<35 and
11% were female aged 16–<20. In contrast, 53% of those
with Perthes were male and aged 20–<35, whereas for
SUFE, half were male and half female. About half of
those with DDH and SUFE were affected in one hip, either
the left or right, and about twice as many of those with
Perthes were unilaterally affected. About three-ﬁfths
(61%) of the sample were working full or part-time, 17%
were in education (school, FE college, or university) and
12% were unable to work due to ill-health. Just over three-
ﬁfths (60–64%) were either deciding what treatment to
have or waiting for treatment for their left or right hip
and 42–44% waiting for or had joint conservation surgery.
Between 9% and 18% of the sample had had a THR in
either the right or left hip, a substantial proportion (35%,
left hip; 31%, right hip) having a THR aged under 30.
Psychometric evaluation
Acceptability, practicality, and patient usefulness
The scale showed good acceptability. There were a number
of questionnaires where the respondent, asked to complete
the instrument while awaiting their outpatient hip appoint-
ment, had not had sufﬁcient time to complete all the
questions (approximately 20). Otherwise, there were very
few missing items. There were low ﬂoor/ceiling effects
(2 for the pain sub-sub-scale and 1 for sport and exercise),
and the majority of sub-scales (6/10) had no extreme
skewness. Exceptions were the pain, sports and exercise,
social life, and overall QoL sub-sub-scales. There was also
good spread over the range of the sub-scales and full scale
(Table 2). Three-quarters of respondents (76%) indicated
that they would ﬁnd the measure useful in their discus-
sions with clinicians (Table 2). For example, it gave the
clinician insight into “the emotional and the physical,” “a
better understanding of my lifestyle” and “its impact on
my everyday life”. Around three-ﬁfths (61%) of those who
indicated that they would not ﬁnd it helpful stated that “ít
was too late” as their treatment was completed or “these
(areas) have already been discussed”.
Reliability
The measure had good internal consistency (Cronbach’s α
=0.98; average ICC =0.98), as did the sub-scales
(Cronbach’s α =0.95- 0.96; average ICC = 0.95-0.96) and
each of the sub-sub-scales (Cronbach’s α =0.85–0.97; ICC
=0.59–0.89) (Table 3). Test–retest reliability remains to be
evaluated in the next stage of the study.
Item analysis
Analysis of all the sub-sub scales indicated substantial
loadings (67–93%) on all items in the one rotated factor
solution, conﬁrming their predicted uni-dimensionality.
The one exception was the QoL sub-sub-scale, which
had two factors; all items except for three (“I don’t feel
good about myself”; “lost my life and identity”; “given up
things I used to do and now have no normal life”) having
high loadings on factor one (0.54–0.86) and the second
comprising predominantly emotion-related items. The two
sub-scales with multiple sub-sub-scale components,
“sport, work, family and social impact” and “psychologi-
cal impact” had, respectively, a three or two factor solu-
tion. For the former, the three factors were: impact on
sports and exercise, impact on social relationships and
education/work, and impact on family life and physical
intimacy. For the latter, the two factors were impact on
body image, and impact on feelings of self-worth and
Table 1 (Continued).
Variable DDH Perthes SUFE
Type of surgery:
right hip
(n=123) (n=18) (n=17)
● Joint conservation 54 (44%) 5 (28%) 2 (12%)
● Triple/femoral osteotomy 5 (4%) 2 (11%) 0 (0%)
● Resurfacing surgery 3 (2%) 0 (0%) 1 (6%)
● Total hip replacement 19 (15%) 4 (22%) 4 (24%)
● Other 7 (6%) 1 (6%) 2 (12%)
● Don’t know 35 (28%) 6 (33%) 8 (47%)
Notes: aThe total number of cases varies due to non-response to particular items, within the total sample size of n=230 (DDH=160; Perthes=35; SUFE=26; PHC not
indicated=9).
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Table 2 Accessibility, practicality, and data quality (n=230)
Practicality
Practicality Mean (SD) Median (range) Non-Respondents Number
(%)
Ease of completion 3.88 (1.06) 4 (3–5) 22 (10.62%)
Time to complete measure (mins) 19.3 (11.91) 15 (10–20) 22 (13.9%)
Help in discussions Not help in discussions
Patient perceived usefulness (%) 76% 24% 37 (16%
Acceptability and data quality
N (%) Missing (scale) Floor/Ceiling (individual items) Skewness (No. Items >1)
No. Items
>60%
No. Items
>80%
Sub-sub-scales
Pain 28 (12% ) 2 0 3
Education & work 9 (4%) 0 0 0
Sport & exercise 125 (54%) 1 0 4
family life 25 (11%) 0 0 0
Physical intimacy 36 (18%) 0 0 0
Social life 88 (38% 0 0 1
Emotion & depession 26 (12%) 0 0 0
Body image 58 (25%) 0 6 0
Conﬁdence & esteem 12 (5%) 0 0 0
Quality of life 45 (20%) 0 0 3
Sub-scales
Pain concerns 28 (12%) 2 0 3
Sport, work, family & social impact 125 (54%) 1 0 5
Psychological impact 58 (25%) 0 0 0
Quality of life impact 45 (20%) 0 0 3
Full scale
Quality of life, concerns and impact 78 (34%) 3 items 0 (11 items)
Scale features
Mean (SD) Median Range Skewness No. Items in Scale
Sub-sub-scale
Pain 56.0 (21.3) 61.8 0–80 −1.04 11
Education & work 48.6 (30.2) 50.0 0–100 0.086 3
Sport & exercise 80.0 (24.6) 82.2 0–100 −1.273 6
Family life 52.9 (30.1) 50.0 0–100 −0.133 3
Physical intimacy 53.8 (31-0.8) 58.3 0–100 −0.174 3
Social life 37.4 (27.4) 35.0 0–100 0.489 5
Emotion & depression 59.7 (25.2) 64.3 0–100 −0.462 6
Body image 38.4 (23.2) 34.3 0–80.0 0.173 7
Conﬁdence & esteem 39.1 (26.2) 37.5 0–100 0.198 6
Quality of life 51.0 (21.1) 52.9 0–80 −0.467 14
(Continued)
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Table 2 (Continued).
Sub-scale
Pain concerns 56.0 (21.3) 61.8 0–80 −1.04 11
Sport, work, family & social impact 40.5 (19.1) 43 0–79 −0.256 20
Psychological impact 41.4 (21.7) 41.1 0–80.0 0.031 19
Quality of life impact 51.0 52.9 0–80 −0.47 14
Full scale
Quality of life, Concerns and impact 43.6 (18.4) 43.3 3.4–77.8 −0.166 64
Table 3 Factor analysis - internal consistency and reliability (n=230)
No.
factors
%
Explained
rotated
Inter-item cor-
relation (range)
Item-total cor-
relation (range)
Cronbach’s
alpha
Interclass
Correlation (aver-
age) (ICC)
Sub-sub-scale
Pain 1 68.5 0.45–0.76 0.62–0.85 ,95 0.95
Education & work 1 77.8 0.56–0.77 0.71–0.77 0.86 0.86
Sport & exercise 1 66.6 0.45–0.79 0.61–0.85 0.91 0.89
Family life 1 76.8 0.46–0.72 0.66–0.77 0.85 0.85
Physical intimacy 1 84.2 0.51 – 0.70 0.78–0.84 0.91 0.91
Social life 1 67.1 0.56–0.81 0.66–0.79 0.88 0.88
Emotion &
depression
1 69.7 0.64–0.88 0.59–0.89 0.91 0.91
Body image 1 65.2 0.43–0.76 0.68–0.85 0.92 0.92
Conﬁdence &
esteem
1 77.3 0.45–0.81 0.67–0.88 0.94 0.94
Quality of life 2 74.5
39% (F1)
35.6% (F2)
0.61–0.88 0.63−0.89 0.97 0.96
Sub-scale
Pain concerns 1 68.5 0.45–0.76 0.62–0.85 ,95 0.95
Sport, work, family
& social impact
3 68.0 (Total)
23.8% (F1)
22.9% (F2)
21.4% (F3)
0.45–0.81 0.61–0.85 0.95 0.97
Psychological
impact
2 68.7
37.2 (FI)
31,5% (F2)
0.43–0.88 0.59–0.89 0.95 0.97
Quality of life
impact
2 74.5
39% (F1)
35.6% (F2)
0.61–0.88 0.63−0.89 0.96 0.96
Full scale
Quality of life,
concerns and
Impact
10 79.5 (Total)
21.2% (F1)
19% (F2)
8.4% (F3)
6.7% (F4)
<6.5% (F5-
F10)
43–0.89 0.59–0.89. 0.98 0.98
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embarrassment. The full measure had a 10-factor solution,
conﬁrming the relevance and appropriateness of the sub-
scale and sub-sub scale components, as indicated in the
ﬁnal model speciﬁcation (Figure 2).
Convergent and divergent validity
Three validated outcome measures – GHQ, i-HOT-12 and
GSE) – were used. Parts of our measure addressed psy-
chological and emotion/depression and QoL impact; these
would be expected to show evidence of convergent valid-
ity with both the GHQ and i-HOT-12. In contrast, diver-
gent validity was assessed against the GSE, as it was not
self-evident or plausible why a relationship, albeit but
small, would be expected with the QoLC&I. As Table 4
shows, the predictions were fulﬁlled. The “psychological
impact” sub-scale and the “QoL impact” sub-scales had,
respectively, moderate convergent validity with GHQ and
high convergent validity with the i-HOT-12. The GSE,
assessing coping, was contrasted with the “psychological
impact” and “sport, work, family and social impact” sub-
scales; a low correlation was found for both. Together,
these results provide supporting evidence for the conver-
gent and divergent validity of the measure.
Discussion
The study has demonstrated that the 64-item QoLC&I
measure, targeted at persons with a PHC aged 16–49
years, is acceptable to patients, has patient relevance,
face and content validity, addresses areas of clinical impor-
tance, and is of potential value to both patients and clin-
icians in their interactions, discussions about treatment
choices and treatment progress. The factor analysis
shows good reliability (internal consistency) and provides
supportive evidence of construct validity. Most impor-
tantly, the measure is grounded in the patient’s perspective,
based on prior qualitative research by the authors. It prio-
rities areas of importance and signiﬁcance to patients with
a PHC and is expressed in a set of understandable, and
patient-derived and validated, Likert-type questions. Two
validation areas remain to be explored - test–retest validity
and responsiveness to change; both will form part of our
next research study. It is also our intention and at the
request of the hip clinicians in our research site at
Birmingham to embark on a program to embed the current
measure into clinical practice, studying these two out-
standing validation aspects alongside.
Amajor purpose behind the design of our measure was to
create a measure directed specially to patients with a PHC, in
contrast to other measures, for example, those reviewed by
Ramisetty et al,18 and one with good coverage of areas
(domains) identiﬁed as important and signiﬁcant to patients.
The mode of administration, via a self-completed question-
naire in a paper or Word format, supports easy and non-time-
consuming completion and facilitates the feasibility and ease
of clinical administration. Furthermore, the language that the
measure is written in has been both derived from, and vali-
dated by, patients and conﬁrmed as clinically relevant by a set
of clinicians in the study site.
The four sub-domains (sub-scales) cover a wide set of
substantive areas, all of importance to patients. This set - pain
concerns; sport, work, family and social impact; psychologi-
cal impact; quality of life impact - has a broader coverage of
key patient concerns than all other existing measures, includ-
ing HAGOS and the iHot-12. This breadth is important, as it
encompasses the perspective of the patient with a PHC;
moreover, it provides clinicians with insight into patient
concerns and the impact of the PHC on their everyday family
life, social relationships, and QoL.
The development of the measure, and its subsequent
emergent validation, provides further evidence on the
Table 4 Convergent and divergent validity (n=230)
Scale Mean (SD) Median Range Skewness No items in scale
GHQ 69.0 (12.4) 70.8 33–100 −0.54 12
iHOT-12 34.7 (23.9) 27.5 0.8–100 1.0 12
GSE 72.2 (16.6) 75.0 25–100 −0.55 10
Contrast measure Measure component(s) Pearson’s correlation (p) Comments
GHQ Psychological impact −0.499 (p<0.001) Moderate
iHOT-12 Quality of life impact −0.822 (p<001) High
GSE Psychological impact −0.235 (p<0.002) Low
GSE Sport, family and social impact −0.245 (p<0.005) Low
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severity and impact of PHCs on patients and their families
in their everyday lives. It also makes it clearer that impact
is not just on QoL, unlike the iHOT-12/33. As noted ear-
lier, the iHOT-33 was developed to address the concerns of
young adult patients with hip disorders but has primarily
been used in patients undergoing arthroscopy.4946 In con-
trast, patients with PHCs are often much more severely
affected by their condition and the surgery is inﬁnitely
more invasive and a much longer recovery period. While
mobility and pain have been measured previously in these
patients (for example, in research studies using WOMAC,
mHHS, and HOS-ADL), our measure also considers the
effect and concerns about impaired mobility and pain,
impact on self-esteem and body image, along with other
areas. Again, speciﬁc measures exist that focus speciﬁcally
and in detail on both constructs (for example, the
Rosenberg self-esteem scale,50 The Body Image
Disturbance Questionnaire BIDQ).51,52 However, these
issues, for those with a PHC, also have a psychological
impact on patients and also affect their social networks and
ability to study or work. Our measure, unlike the i-HOT-
12, explores psychological impact, as one core domain,
along with impact on work/education and overall QoL.
The qualitative work ensured that the measure was
patient-centered and covered areas that patients felt were
important. There were some important differences to other
measures described in the literature review within arthritis,
for example, less emphasis on pain and function and
greater emphasis on self-esteem and body image. It is
evident from our work that issues surrounding self-
esteem and body image can arise speciﬁcally in patients
with PHCs, related to the difﬁculties they have with mobi-
lity and posture. In addition, such patients are much
younger than those who traditionally suffer from arthritis.
They are mainly aged 18–40. Any chronic illness is likely
greatly to affect education, work, family, and social life
and more so than for older adults. Due to societal pres-
sures to conform to social and physical stereotypes, PHC
patients are also more likely to suffer self-esteem, conﬁ-
dence, and body image issues. Their psychological impact
is likely to be profound and to affect several psychological
constructs, including emotion and depression, body image,
conﬁdence, and self-esteem. PHC patients are more likely
to display these psychological effects as they face life-
changing events such as going to university, starting
work and having children.
The measure was developed to be used alongside other
clinically focused measures in clinical trials or longitudinal
outcome studies. Use of the QoLC&I in these studies would
facilitate a better understanding of this patient group and gain
additional insight into the physical and psychological impact
of PHCs. Further knowledge of the psychological impact of
PHCs would encourage development of psychological inter-
ventions to support patient recovery. Following further vali-
dation, the QoLC&I measure could also be used to identify
patients who had become physically or psychologically
impaired. As the management of painful borderline dysplas-
tic hip is an issue of great controversy and is common in
young adults with hip pain (a reported prevalence of 37.6%
in selected patient hip dysplasia cohorts)53 our measure
might support decision making, with such cases.
Knowing the overall impact that a PHC has on the
individual, physically and socially and psychologically,
would help to inform decisions about treatment options
and type of surgery. Clinicians in our study who have used
the measure reported that it helped support conversations
with patients about QoL, psychological impact, and socio-
economic impact. It was also easy to use and could be
completed before a consultation and then discussed within
the consultation. Moreover, patients liked using the mea-
sure as it prompted clinicians to ask about wider issues.
Future work needs to consider in detail how the measure
informs decision making.
Study strengths and limitations
The study has a number of strengths. First, the develop-
ment of the measure was based on our previous DDH
qualitative studies,3,4 which explored participants’ experi-
ences from their stories about their everyday life with
DDH and piloting of the emerging measure with a subset
of these participants. Second, the reﬁned measure was
further piloted with a set of clinicians in the research site
in relation to clinical utility and feasibility of use in routine
clinical practice. Third, an adequate sample size was
achieved for the development and psychometric validation
of the measure.
The study also has a number of limitations. First,
participants in the qualitative study were self-selecting,
responding to requests for participants on the web forums.
It could be the case that the more vocal and potentially
wishing to put forward strong views were more likely to
take part. Second, there was potential self-selection in
terms of who might seek, join, and make use of the web
forums, as a source of support and advice. The bias effect
of both of these cannot be assessed. Recruitment from
dedicated PHC web forums is one of the few ways to
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access a diversity of participants; moreover, web forums
are becoming a common and well-utilized mode for per-
sons with a particular ill-health condition to gain insight
into others’ experiences and as a source of support and
advice.54,55,56 Thirdly, the validation study was conducted
in a single, specialist hip site, and valuably one where
patients with one of the PHCs were referred to for specia-
list treatment. Interpretation of the study ﬁndings should
take heed of these limitations. Further validation, in parti-
cular of test–retest validity and responsiveness to change,
in additional specialist hip clinics would be valuable.
Further research
Further research areas include psychometric evaluation in
additional specialist hip clinics, extension of the evaluation
to explore test–retest reliability and responsiveness to
change, and embedding the ﬁnal measure into routine clinical
practice, especially in secondary specialist care and rehabili-
tation. Additionally, the study’s ﬁndings could valuably be
disseminated into primary care, to extend the insight of GPs
and physiotherapists to PHCs and signiﬁcant issues of key
importance to persons with a hip condition, with subsequent
study of its impact. At present, it is evident from our quali-
tative study that such persons are often wrongly perceived as,
for example, having a groin strain or their symptoms being
part of the maturity process, and thus often dismissed and
inappropriately treated; this has signiﬁcant impact on the
delays to deﬁnitive diagnosis and referral to specialist hip
treatment and care.2,3,4
High-quality clinical research in PHC orthopedic surgery
is beginning to emerge, previously predominantly being
observational case series.53 One of the barriers to developing
randomized controlled trials in this area is a paucity of robust
outcome measures that access the range of desirable out-
comes, thus the potential signiﬁcance of our QoLC&I mea-
sure, and its capturing outcomes that are meaningful to the
patient population and consider the wider impact of the
conditions. Perry et al57 identiﬁed several priority areas that
hip surgeons considered of high importance to study. All
three PHCs featured among these priorities. For example,
one aspect was phrased as “what are the current approaches
used in the management of late presenting hip dysplasia in
infants, and how may differences in treatment choices inﬂu-
ence outcomes?” For research to be beneﬁcial to the patient
group more meaningful outcome measures will need to be
developed, for example, in Perthes where we, with collea-
gues in Liverpool, have been developing and testing a young-
child friendly and self-completed measure.28
Conclusion
Patient-related outcomes measures should correspond to
speciﬁc clinical situations and bring the opportunity to
improve quality of care.58 An outcome measure must not
only demonstrate the expected methodological properties
and performance but also offer a positive contribution to
patient care. The study has demonstrated that the 64-item
QoLC&I measure is acceptable to patients, has patient
relevance, addresses areas of clinical importance, and is
of potential value to both patients and clinicians in their
discussions about treatment choices and treatment pro-
gress. Most importantly, the measure is grounded in the
patient’s perspective, based on prior qualitative research. It
priorities areas of importance and signiﬁcance to patients
with a PHC and is expressed in a set of understandable,
and patient-derived and validated, Likert-type questions.
Measuring these important outcomes will enable us to
learn more about the overall impact of PHC and facilitate
the development of interventions which are focused on
addressing the broader impact of the condition. Further
work should focus on further psychometric testing and
embedding the measure into clinical practice.
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